Endovascular Therapy Combined With Tirofiban for Intracranial Atherosclerotic Acute Ischemic Stroke

NARecruitingINTERVENTIONAL
Enrollment

716

Participants

Timeline

Start Date

August 15, 2025

Primary Completion Date

March 1, 2027

Study Completion Date

April 1, 2027

Conditions
Acute Ischemic Stroke
Interventions
DRUG

Tirofiban

After endovascular treatment, tirofiban is infused at a rate of 0.4 μg/kg/min for 30 minutes, followed by a maintenance infusion at 0.1 μg/kg/min until 24 hours postoperatively.

DRUG

Placebo

Following endovascular treatment, patients receive normal saline placebo, with the dosage calculated in the same manner as that of tirofiban in the experimental group.

Trial Locations (1)

101118

RECRUITING

Beijing Anzhen Hospital Affiliated to Capital Medical University, Beijing

All Listed Sponsors
lead

Beijing Anzhen Hospital

OTHER

NCT07026318 - Endovascular Therapy Combined With Tirofiban for Intracranial Atherosclerotic Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter